FLXN News 14.53 Flexion Therapeutics Inc (FLXN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Flexion Therapeutics Inc (FLXN) 14.53 $FLXN

Flexion Therapeutics to Present at the 13th Annual Needham Healthcare Conference
GlobeNewswire - Wed Apr 02, 8:43AM CDT
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that CEO Michael Clayman, M.D., will present an overview of the company at the 13th Annual Needham Healthcare Conference. Dr. Clayman's presentation is scheduled for April 9, 2014, at 1:40 p.m. Eastern Time. The conference will take place April 8-9, 2014, at The Westin New York Grand Central.

Flexion Reports Year-End 2013 Financial Results
GlobeNewswire - Thu Mar 27, 7:14AM CDT
- Strong cash position bolstered with additional $75 million from IPO -

Flexion Therapeutics to Report Year-End 2013 Earning Results on March 27, 2014
GlobeNewswire - Thu Mar 20, 3:00PM CDT
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that it will host a conference call and webcast to report its year-end 2013 financial results on Thursday, March 27, 2014, at 4 p.m. ET.

Flexion Therapeutics to Present at the 34th Annual Cowen Health Care Conference
GlobeNewswire - Wed Feb 26, 8:22AM CST
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that CEO Michael Clayman, M.D., will present an overview of the company at the 34 Annual Cowen Health Care Conference. Dr. Clayman's presentation is scheduled for March 3, 2014, at 4:50 p.m. Eastern Time. The Conference will take place March 3-5, 2014, at The Boston Marriott Copley Place.

Flexion Therapeutics reports IPO of 5.75m shares of common stock, including underwriters' option
M2 - Wed Feb 19, 5:14AM CST
Pharmaceutical company Flexion Therapeutics Inc (NasdaqGM:FLXN) said on Tuesday that it has completed the initial public offering of 5,750,000 shares of its common stock.

Flexion Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire - Tue Feb 18, 4:00PM CST
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today the closing of its initial public offering of 5,750,000 shares of its common stock at an initial public offering price of $13.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional shares of common stock. Flexion offered all of the shares of common stock. The aggregate net proceeds to Flexion, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $67.3 million.

Talmer, Eagle Pharma, Flexion up in trading debuts
AP - Wed Feb 12, 10:17AM CST
NEW YORK (AP) — Three companies, a bank and two drug developers, making their market debuts are trading higher on Wednesday on the Nasdaq.

Flexion Therapeutics Announces Pricing of Initial Public Offering
GlobeNewswire - Tue Feb 11, 5:03PM CST
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $13.00 per share. The shares are scheduled to begin trading on the NASDAQ Global Market under the ticker symbol "FLXN" on February 12, 2014. Flexion is offering all of the shares of common stock. Flexion has also granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock. The offering is expected to close on February 18, 2014, subject to customary closing conditions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hebrew Learning Made Simple: Expert's Structured Guide

Updated Category News Views 0

Cracking the Hebrew Code: A Balanced Guide Ever tried staring down a new language script and felt like you were on a sinking ship? That’s where a lot of folks starting off with Hebrew reading find themselves. It's no sunny stroll through a Greek alphabet park—Hebrew's a whole different ballgame. But Diana Yacobi from Sarah & David’s Read Hebrew Now offers a roadmap...

Continue Reading
Flor de Caña's Green Strategy Wins 2026 Stevie Award

Updated Category News Views 52

Flor de Caña’s Environmental Triumph Seems like when folks think of premium rum, they might wanna start picturing not just smooth sips but a green commitment that runs deep. Flor de Caña has bagged a Stevie Award for their solid 'Net Zero Strategy of the Year.' This ain’t just any award; it's a nod from a respected crowd. A handshake from the business big shots who...

Continue Reading
Timken Maintains Robust Dividend Streak in 2026

Updated Category News Views 0

Timken Keeps Dividend Train Rolling You want to talk consistency? Timken Company just declared its quarterly dividend like clockwork. As a stockholder, that might just be your morning coffee fix before anything else. Notably, Timken's been on the NYSE since 1922, having cranked out 418 consecutive dividend payouts. That's like your grandpa never missing a Sunday golf...

Continue Reading
NYSE Gains Ground with Historic Listings Transfers

Updated Category News Views 130

You'll know it's a topsy-turvy market when hefty firms start switching their stock exchange allegiance. This year, nine noteworthy companies, with a collective market heft of nearly half a trillion dollars, kissed Nasdaq goodbye and nestled into the New York Stock Exchange (NYSE). Now, why would these big shots make the shift, you ask? Let's dive into the nitty-gritty....

Continue Reading
AiPrise Token Sharing Streamlines Compliance Tasks

Updated Category News Views 107

Streamlining the Redundant Chore of Compliance Now, here's something with teeth. AiPrise rolls out its Token Sharing infrastructure, a crafty solution to a common hassle—duplicated compliance work. It's a game changer for financial institutions that find themselves drowning in a sea of repetitive verification tasks. The notion of sharing verified customer data among...

Continue Reading
B2K's Comeback with ECLIPSE Breaks Records

Updated Category News Views 120

Resurgence in the R&B World Well, if you told me B2K would make a grand return and rock the charts after 24 years, I'd have laughed. But it's happening—like a seasoned player making a comeback in overtime. The platinum-selling R&B group B2K launched a new album, 'ECLIPSE,' tied to their 'Boys 4 Life Tour.' The Innovative Marketing Strategy In a move that might just...

Continue Reading
New Intubation Blade: A Potential Game-Changer in EMS

Updated Category News Views 91

Streamlining Emergency Medical Procedures A seasoned paramedic from Norfolk, Virginia, with a knack for solving practical problems, has devised a tool that could revolutionize the emergency medical field: the Dual Purpose Intubation Blade. This innovation is not just about simplifying the intubation process; it’s about taking a massive step forward in how emergency...

Continue Reading
Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 24

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
NJ Water Boosts Fire & EMS Grants to $5K in 2027

Updated Category News Views 70

Water Utility Backs First Responders with Bigger Bucks Listen up, folks. The New Jersey American Water company just threw down the gauntlet with some bold moves for its 2027 Volunteer Fire and EMS Grant Program. They've taken the maximum grant amount from $2,500 to $5,000. Yeah, you heard right. Doubling the pot and starting the application cycle earlier means volunteer...

Continue Reading
Keurig Dr Pepper's $2B Debt Reduction: Strategic Move?

Updated Category News Views 53

Beverage Giant Keurig Dr Pepper Selling Big on Stock In the latest twist from the executive suite of Keurig Dr Pepper (NASDAQ: KDP), they've just pushed out a hefty public offering of nearly 58 million shares at $34.50 a pop. We're talking over a two billion dollar game plan here, folks. The deadline for this brew of equity grabs ends November 16, 2026, if all the...

Continue Reading

Top 5 Most Recently Viewed Articles

Avadel's Board Evaluates Lundbeck's Proposal for Acquisition

Updated Category News Views 195

Avadel Pharmaceuticals Evaluates Lundbeck's Acquisition Proposal Avadel Pharmaceuticals plc (Nasdaq: AVDL) has recently found itself in the corporate spotlight as the company's Board of Directors thoroughly evaluates a new acquisition proposal from H. Lundbeck A/S. This unsolicited proposition has been categorized as a "Company Superior Proposal," which invites intriguing...

Continue Reading
ESET Highlights Growing Threats from AI and NFC Technologies

Updated Category News Views 129

ESET Unveils Critical Trends in Cybersecurity Threats The latest threat landscape trends from ESET Research highlight a significant evolution in AI-driven attacks and the proliferation of NFC threats. These insights are compiled in their recently released H2 2025 Threat Report, detailing cyber threats observed between June and November. Emergence of AI-driven Malware In...

Continue Reading
Insights on Man Group PLC's Stake in American Axle & Manufacturing

Updated Category News Views 145

Understanding Man Group PLC's Disclosure of Interests Man Group PLC, a notable player in the investment sector, has recently made a significant disclosure concerning its position in American Axle & Manufacturing Holdings, Inc. This disclosure, part of regulatory requirements, provides a detailed view of Man Group PLC's holdings. By understanding these positions,...

Continue Reading
Centene Corporation's Second Quarter Results Highlights 2025

Updated Category News Views 663

Financial Overview of Centene Corporation's Second Quarter Centene Corporation (NYSE: CNC) recently shared its financial results for the second quarter of 2025, showing a diluted loss per share of $(0.51) and an adjusted diluted loss per share of $(0.16). The company generated total revenues of $48.7 billion, reflecting the financial complexities of the health care...

Continue Reading
S Hotel Montego Bay Named Top Caribbean Destination in 2024

Updated Category News Views 115

S Hotel Montego Bay Achieves Top Recognition in the Caribbean This year marks a notable achievement for the S Hotel Montego Bay. As revealed by Condé Nast Traveler, this luxurious hotel has clinched the coveted title of the #1 hotel in the Caribbean and Central America for the year 2024. This recognition is particularly significant as it celebrates the ongoing commitment...

Continue Reading